Call Us
+919016820285
Contact Us For Help
Products

Sevoflurane

Sevoflurane

Product Details:

  • Drug Type Other Types
  • Ingredients Sevoflurane
  • Physical Form Liquid
  • Dosage As Directed By Physician
  • Dosage Guidelines As directed by physician.
  • Suitable For Adults
  • Quantity 50 ml, 250 ml Unit
  • Supply Ability : 100000 Box Per Month
55.66 USD ($)
X

Price And Quantity

  • As required by client. Box
  • 55.66 USD ($)

Product Specifications

  • Sevoflurane
  • As directed by physician.
  • 50 ml, 250 ml Unit
  • Other Types
  • As Directed By Physician
  • Adults
  • Liquid
  • Store in Cool & Dry Place

Trade Information

  • Hazira / Nhava Sheva
  • Cash in Advance (CID), Telegraphic Transfer (T/T), Cash Advance (CA)
  • 100000 Box Per Month
  • 1 Week
  • Yes
  • If order is confirmed we will reimburse the sample cost
  • Packing : 50 ml, 250 ml Pack Insert/Leaflet : Yes
  • WHO-GMP/ GMP/ COA/ As Required By Client

Product Description

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.

It is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia, across all ages, as well as in veterinary medicine. Together with desflurane, sevoflurane is replacing isoflurane and halothane in modern anesthesiology. It is often administered in a mixture of nitrous oxide and oxygen.

Sevoflurane "has an excellent safety record", but is under review for potential neurotoxicity, especially relevant to administration in infants and children, and rare reports similar to halothane hepatotoxicity. Sevoflurane is the preferred agent for mask induction due to its lesser irritation to mucous membranes.

Sevoflurane was discovered by Ross Terrel and independently by Bernard M Regan. A detailed report of its development and properties appeared in 1975 in a paper authored by Richard Wallin, Bernard Regan, Martha Napoli and Ivan Stern. It was introduced into clinical practice initially in Japan in 1990 by Maruishi Pharmaceutical Co., Ltd. Osaka, Japan. The rights for sevoflurane worldwide were held by AbbVie. It is now available as a generic drug.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:
Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK), Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.

Tags
Sevoflurane Vaporizer Manufacturers India Sevoflurane Vaporizer suppliers India Sevoflurane Vaporizer Exporters India Sevoflurane Vaporizer Wholesalers India Sevoflurane Vaporizer Distributors India Sevoflurane Vaporizer Dropshipper India Sevoflurane Vaporizer Bulk Drugs Suppliers India Buy Sevoflurane Vaporizer Online India Sevoflurane Vaporizer Price Generic Sevoflurane Vaporizer SupplierBuy Generic Sevoflurane Vaporizer Online IndiaSevoflurane Vaporizer Trader India Sevoflurane VaporizerSevotroy


SALVAVIDAS PHARMACEUTICAL PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.